PDB Short entry for 2D7O HEADER STRUCTURAL PROTEIN 24-NOV-05 2D7O TITLE SOLUTION STRUCTURE OF THE 17TH FILAMIN DOMAIN FROM HUMAN FILAMIN C COMPND MOL_ID: 1; COMPND 2 MOLECULE: FILAMIN-C; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FILAMIN DOMAIN; COMPND 5 SYNONYM: GAMMA-FILAMIN, FILAMIN-2, PROTEIN FLNC, ACTIN-BINDING-LIKE COMPND 6 PROTEIN, ABP-L, ABP-280-LIKE PROTEIN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FLNC; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P050404-10; SOURCE 8 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS BETA-SANDWICH, IMMUNOGLOBULIN-LIKE FOLD, FILAMIN DOMAIN, STRUCTURAL KEYWDS 2 GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND KEYWDS 3 FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 4 INITIATIVE, RSGI, STRUCTURAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.TOMIZAWA,T.KIGAWA,S.KOSHIBA,M.INOUE,S.YOKOYAMA,RIKEN STRUCTURAL AUTHOR 2 GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 09-MAR-22 2D7O 1 REMARK SEQADV REVDAT 2 24-FEB-09 2D7O 1 VERSN REVDAT 1 24-MAY-06 2D7O 0 JRNL AUTH T.TOMIZAWA,T.KIGAWA,S.KOSHIBA,M.INOUE,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE 17TH FILAMIN DOMAIN FROM HUMAN JRNL TITL 2 FILAMIN C JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2D7O COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000025089. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.16MM FILAMIN DOMAIN U-15N,13C; REMARK 210 20MM D-TRIS-HCL(PH 7.0); 100MM REMARK 210 NACL; 1MM D-DTT; 0.02% NAN3; 10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20030801, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.932, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 RESTRAINTED MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION,STRUCTURES WITH REMARK 210 THE LOWEST ENERGY,STRUCTURES REMARK 210 WITH THE LEAST RESTRAINT REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 3 41.96 39.32 REMARK 500 1 ALA A 8 171.05 -48.50 REMARK 500 1 HIS A 23 -176.35 -173.37 REMARK 500 1 GLU A 41 112.90 -36.79 REMARK 500 1 PRO A 51 2.54 -69.74 REMARK 500 1 SER A 52 143.61 -172.50 REMARK 500 1 LYS A 62 29.49 36.71 REMARK 500 1 PRO A 90 82.87 -69.78 REMARK 500 1 SER A 109 -60.38 -121.77 REMARK 500 2 SER A 2 94.99 -69.62 REMARK 500 2 HIS A 13 148.74 -172.64 REMARK 500 2 HIS A 23 -176.67 -174.96 REMARK 500 2 PRO A 29 93.25 -69.73 REMARK 500 2 ALA A 30 97.55 -67.46 REMARK 500 2 VAL A 35 99.62 -67.98 REMARK 500 2 GLU A 41 120.83 -35.69 REMARK 500 2 ASP A 86 33.35 72.72 REMARK 500 2 PRO A 90 83.35 -69.81 REMARK 500 2 ASP A 101 134.87 -172.90 REMARK 500 2 MET A 104 43.18 34.89 REMARK 500 2 SER A 106 117.08 -171.18 REMARK 500 3 VAL A 35 92.37 -68.65 REMARK 500 3 PRO A 51 0.96 -69.82 REMARK 500 3 SER A 52 145.85 -173.76 REMARK 500 3 ASP A 63 -44.92 -133.04 REMARK 500 3 ASP A 86 41.71 72.93 REMARK 500 3 PRO A 90 82.18 -69.82 REMARK 500 3 ASP A 102 140.44 -39.06 REMARK 500 3 SER A 109 39.87 71.33 REMARK 500 4 ALA A 8 110.76 -169.35 REMARK 500 4 HIS A 23 -176.79 -170.28 REMARK 500 4 GLU A 41 118.29 -37.09 REMARK 500 4 LYS A 62 28.82 46.44 REMARK 500 4 ASP A 86 40.00 70.64 REMARK 500 4 PRO A 90 81.46 -69.72 REMARK 500 5 SER A 11 110.60 -174.48 REMARK 500 5 VAL A 35 97.50 -68.03 REMARK 500 5 GLU A 41 125.79 -39.88 REMARK 500 5 PRO A 90 85.04 -69.72 REMARK 500 6 SER A 5 105.85 -47.48 REMARK 500 6 HIS A 23 -179.45 -171.98 REMARK 500 6 PRO A 29 98.47 -69.78 REMARK 500 6 VAL A 35 97.82 -68.02 REMARK 500 6 ASP A 86 39.90 70.48 REMARK 500 6 PRO A 90 83.99 -69.81 REMARK 500 6 ASP A 102 43.73 -101.32 REMARK 500 6 SER A 106 -61.86 -91.13 REMARK 500 7 ASN A 10 96.98 -37.40 REMARK 500 7 SER A 11 105.05 -160.07 REMARK 500 7 HIS A 13 143.77 -174.90 REMARK 500 REMARK 500 THIS ENTRY HAS 142 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK003000177.4 RELATED DB: TARGETDB DBREF 2D7O A 8 105 UNP Q14315 FLNC_HUMAN 1856 1953 SEQADV 2D7O GLY A 1 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O SER A 2 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O SER A 3 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O GLY A 4 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O SER A 5 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O SER A 6 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O GLY A 7 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O SER A 106 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O GLY A 107 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O PRO A 108 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O SER A 109 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O SER A 110 UNP Q14315 CLONING ARTIFACT SEQADV 2D7O GLY A 111 UNP Q14315 CLONING ARTIFACT SEQRES 1 A 111 GLY SER SER GLY SER SER GLY ALA ILE ASN SER ARG HIS SEQRES 2 A 111 VAL SER ALA TYR GLY PRO GLY LEU SER HIS GLY MET VAL SEQRES 3 A 111 ASN LYS PRO ALA THR PHE THR ILE VAL THR LYS ASP ALA SEQRES 4 A 111 GLY GLU GLY GLY LEU SER LEU ALA VAL GLU GLY PRO SER SEQRES 5 A 111 LYS ALA GLU ILE THR CYS LYS ASP ASN LYS ASP GLY THR SEQRES 6 A 111 CYS THR VAL SER TYR LEU PRO THR ALA PRO GLY ASP TYR SEQRES 7 A 111 SER ILE ILE VAL ARG PHE ASP ASP LYS HIS ILE PRO GLY SEQRES 8 A 111 SER PRO PHE THR ALA LYS ILE THR GLY ASP ASP SER MET SEQRES 9 A 111 ARG SER GLY PRO SER SER GLY HELIX 1 1 GLY A 18 SER A 22 1 5 SHEET 1 A 3 SER A 15 TYR A 17 0 SHEET 2 A 3 ALA A 30 VAL A 35 -1 O VAL A 35 N SER A 15 SHEET 3 A 3 THR A 65 TYR A 70 -1 O TYR A 70 N ALA A 30 SHEET 1 B 4 HIS A 23 MET A 25 0 SHEET 2 B 4 PHE A 94 THR A 99 1 O LYS A 97 N GLY A 24 SHEET 3 B 4 GLY A 76 ILE A 81 -1 N TYR A 78 O ALA A 96 SHEET 4 B 4 ALA A 47 GLU A 49 -1 N GLU A 49 O SER A 79 CISPEP 1 SER A 92 PRO A 93 1 -0.05 CISPEP 2 SER A 92 PRO A 93 2 -0.06 CISPEP 3 SER A 92 PRO A 93 3 0.02 CISPEP 4 SER A 92 PRO A 93 4 0.01 CISPEP 5 SER A 92 PRO A 93 5 -0.05 CISPEP 6 SER A 92 PRO A 93 6 -0.01 CISPEP 7 SER A 92 PRO A 93 7 -0.04 CISPEP 8 SER A 92 PRO A 93 8 0.02 CISPEP 9 SER A 92 PRO A 93 9 -0.01 CISPEP 10 SER A 92 PRO A 93 10 -0.04 CISPEP 11 SER A 92 PRO A 93 11 -0.06 CISPEP 12 SER A 92 PRO A 93 12 -0.01 CISPEP 13 SER A 92 PRO A 93 13 0.05 CISPEP 14 SER A 92 PRO A 93 14 -0.09 CISPEP 15 SER A 92 PRO A 93 15 -0.01 CISPEP 16 SER A 92 PRO A 93 16 -0.05 CISPEP 17 SER A 92 PRO A 93 17 -0.02 CISPEP 18 SER A 92 PRO A 93 18 0.05 CISPEP 19 SER A 92 PRO A 93 19 -0.05 CISPEP 20 SER A 92 PRO A 93 20 -0.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000